Technical Analysis for NARI - Inari Medical, Inc.

Grade Last Price % Change Price Change
C 49.66 -0.18% -0.09
NARI closed down 0.18 percent on Friday, November 22, 2024, on 71 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
NR7 Range Contraction 0.00%
Multiple of Ten Bearish Other 0.00%
Crossed Above 20 DMA Bullish -0.18%
Multiple of Ten Bearish Other -0.18%
Inside Day Range Contraction -0.18%
Fell Below 20 DMA Bearish 1.35%
Multiple of Ten Bearish Other 1.35%
Inside Day Range Contraction -2.57%
Gapped Down Weakness -2.57%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 14 hours ago
Fell Below 20 DMA about 18 hours ago
20 DMA Support about 19 hours ago
Rose Above Previous Day's High about 19 hours ago
Up 1% about 19 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Inari Medical, Inc. Description

Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari is focused on treating venous thromboembolism and improving the quality of life of patients suffering from this disease by safely and effectively removing blood clots. Inari has developed two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The ClotTriever system is 510(k)-cleared by the FDA for thrombectomy in the peripheral vessels and is used to treat patients suffering from deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA for the treatment of pulmonary embolism.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Disease FDA Catheter Hematology Quality Of Life Veins Thrombosis Angiology Blood Clots Deep Vein Thrombosis Embolectomy Pulmonary Embolism Thrombectomy Thrombus Venous Diseases Venous Thrombosis

Is NARI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 67.13
52 Week Low 36.73
Average Volume 861,259
200-Day Moving Average 46.73
50-Day Moving Average 45.66
20-Day Moving Average 49.87
10-Day Moving Average 50.59
Average True Range 2.11
RSI (14) 53.49
ADX 29.33
+DI 21.84
-DI 16.57
Chandelier Exit (Long, 3 ATRs) 47.33
Chandelier Exit (Short, 3 ATRs) 48.77
Upper Bollinger Bands 54.42
Lower Bollinger Band 45.32
Percent B (%b) 0.48
BandWidth 18.26
MACD Line 1.27
MACD Signal Line 1.63
MACD Histogram -0.359
Fundamentals Value
Market Cap 2.86 Billion
Num Shares 57.6 Million
EPS -0.05
Price-to-Earnings (P/E) Ratio -993.20
Price-to-Sales 7.22
Price-to-Book 7.50
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 51.25
Resistance 3 (R3) 51.36 50.93 50.99
Resistance 2 (R2) 50.93 50.53 50.88 50.90
Resistance 1 (R1) 50.30 50.28 50.09 50.19 50.81
Pivot Point 49.87 49.87 49.77 49.82 49.87
Support 1 (S1) 49.24 49.47 49.03 49.13 48.51
Support 2 (S2) 48.81 49.22 48.76 48.42
Support 3 (S3) 48.18 48.81 48.34
Support 4 (S4) 48.07